FTC Suit Against Cephalon’s Reverse Settlements Focuses On Side Deals
Agency claims that Cephalon's deals with four generic companies constitute unfair competition under the FTC Act.
Agency claims that Cephalon's deals with four generic companies constitute unfair competition under the FTC Act.